Skip to main content

Sign up for our newsletter.

Quality journalism. Progressive values. Direct to your inbox.

For Immediate Release

Press Release

Trump Completes Big Pharma’s Takeover of America’s Health Care With Nomination of Alex Azar to Head HHS

Statements of Public Citizen Experts
WASHINGTON -

Note: President Donald Trump today has nominated Alex Azar to be the next U.S. Secretary of Health and Human Services (HHS). Azar served for five years as president of Lilly USA, LLC, the largest affiliate of global biopharmaceutical leader Eli Lilly and Company.

Just weeks after denouncing “out-of-control” prescription prices, President Donald Trump shows he doesn’t mean it by nominating a former pharmaceutical company executive to run the U.S. Department of Health and Human Services. If Alex Azar’s nomination is confirmed, then Big Pharma’s coup d’etat in the health care sphere will be virtually complete.

In his public statements, Alex Azar has made clear that he is opposed to measures to restrain prescription companies’ profiteering and limit improper marketing, while favoring weaker safety approval standards.

Americans understand, passionately, that price gouging leads to rationing of care. It is unethical and must end. Even President Trump says so. But it is highly unlikely that a pharmaceutical company executive who has made passionate arguments against price restraints is going to advance real reform. Much more likely is that he serves as the instrument by which Big Pharma aims to defend its monopolies and unaffordable prices.

The swamp only gets worse. Tom Price supported Big Pharma in the U.S. Congress. Now apparently Trump has decided to cut out the middleman and let a pharmaceutical executive literally run the federal department that protects the health of all Americans.

-Robert Weissman, president, Public Citizen

As Tweeter-in-Chief, Trump tells us Azar will be a ‘star’ who will lower prescription prices. Maybe he should have asked the six million diabetic Americans whose insulin prices have more than tripled under Azar’s watch at Eli Lilly. Eli Lilly is notorious for spiking prices of this century-old isolated hormone. During Azar’s tenure as president and vice president, Eli Lilly raised the price of Humalog by 345 percent from $2,657.88 per year to $9,172.80 per year.

-Peter Maybarduk, director, Public Citizen's Access to Medicines Program

###

Public Citizen is a nonprofit consumer advocacy organization that champions the public interest in the halls of power. We defend democracy, resist corporate power and work to ensure that government works for the people – not for big corporations. Founded in 1971, we now have 500,000 members and supporters throughout the country.

EPA's Environmental Justice Office 'Won't Make Up for' Manchin Deal, Campaigner Says

"We've seen a lot of structural changes on environmental justice in the Biden, Obama and Clinton administrations, but we need to see the results," said Wes Gobar of the Movement for Black Lives.

Julia Conley ·


Historic Tropical Storm Fiona Sweeps Homes Into Ocean in Eastern Canada

"Climate change leads to warmer ocean water at higher latitudes," said one Canadian civil engineering professor. "A warmer future increases the probability that more intense storms will reach Canadian coasts."

Julia Conley ·


Federal Judge Allows 'Untenable' Plan to Send Juvenile Inmates to Angola Prison

"The move defies all common sense and best practices, and it will cause irrevocable damage to our youth and families," said one children's advocate.

Julia Conley ·


'Catastrophic': Arizona Judge Allows 1864 Abortion Ban to Go Into Effect

"No archaic law should dictate our reproductive freedom," said one rights advocate.

Julia Conley ·


US Progressives Express Solidarity With Iranian Protesters After Death of Mahsa Amini

"The right to choose belongs to us all, from hijabs to reproductive care," said Rep. Alexandria Ocasio-Cortez.

Julia Conley ·

Common Dreams Logo